Table II.
Pediatric (< 20 years) | Gender | Primary site | Staging | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||
Histology | M | F | H&N | Ab | Intra-T | Trunk | Extre | Others | L | R | D | U | |
| |||||||||||||
Total N | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | |
RMS | 1668 | 58.8 | 41.2 | 35.1 | 18.0 | 1.0 | 29.1 | 13.4 | 3.4 | 31.1 | 31.8 | 27.4 | 9.7 |
Fibroblastic | 286 | 49.3 | 50.7 | 18.9 | 6.6 | 2.4 | 25.5 | 44.8 | 1.7 | 55.6 | 23.1 | 7.0 | 14.3 |
Fibrohistiocytic | 547 | 47.5 | 52.5 | 15.4 | 0.4 | 0.7 | 34.9 | 47.3 | 1.3 | 58.3 | 30.2 | 2.6 | 9.0 |
MPNST | 217 | 52.5 | 47.5 | 17.5 | 13.8 | 1.8 | 27.2 | 33.6 | 6.0 | 48.8 | 24.0 | 14.7 | 12.4 |
Kaposi | 15 | 80.0 | 20.0 | 13.3 | 0.0 | 0.0 | 13.3 | 26.7 | 46.7 | 0.0 | 0.0 | 0.0 | 100.0 |
Ewing family tumors | 233 | 56.7 | 43.3 | 11.6 | 7.3 | 3.0 | 49.4 | 24.9 | 3.9 | 30.0 | 32.6 | 26.6 | 10.7 |
Rhabdoid | 44 | 56.8 | 43.2 | 29.5 | 9.1 | 6.8 | 27.3 | 20.5 | 6.8 | 29.5 | 27.3 | 31.8 | 11.4 |
Liposarcomas | 87 | 48.3 | 51.7 | 8.0 | 4.6 | 3.4 | 18.4 | 63.2 | 2.3 | 67.8 | 19.5 | 3.4 | 9.2 |
Leiomyosarcomas | 112 | 48.2 | 51.8 | 14.3 | 33.0 | 1.8 | 22.3 | 27.7 | 0.9 | 50.9 | 24.1 | 15.2 | 9.8 |
Synovial | 328 | 55.2 | 44.8 | 5.8 | 1.5 | 1.2 | 15.5 | 75.3 | 0.6 | 61.6 | 23.2 | 9.5 | 5.8 |
Blood vessel | 57 | 54.4 | 45.6 | 12.3 | 12.3 | 8.8 | 15.8 | 36.8 | 14.0 | 42.1 | 10.5 | 28.1 | 19.3 |
Osseous\chondromatous | 26 | 57.7 | 42.3 | 7.7 | 0.0 | 0.0 | 26.9 | 61.5 | 3.8 | 26.9 | 38.5 | 26.9 | 7.7 |
ASPS | 47 | 38.3 | 61.7 | 27.7 | 2.1 | 0.0 | 14.9 | 55.3 | 0.0 | 55.3 | 17.0 | 23.4 | 4.3 |
Miscellaneous | 480 | 53.1 | 46.9 | 15.8 | 14.4 | 2.5 | 30.2 | 31.5 | 5.6 | 40.0 | 18.5 | 26.7 | 14.8 |
Adult (20 + years) | Gender | Primary site | Staging | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||
Histology | M | F | H&N | Ab | Intra-T | Trunk | Extre | Others | L | R | D | U | |
| |||||||||||||
Total N | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | Row % | |
RMS | 1163 | 54.6 | 45.4 | 19.5 | 20.9 | 3.8 | 24.7 | 25.5 | 5.6 | 31.6 | 25.9 | 29.0 | 13.5 |
Fibroblastic | 2751 | 49.7 | 50.3 | 16.5 | 11.0 | 6.8 | 29.4 | 33.4 | 2.8 | 53.8 | 18.5 | 9.5 | 18.3 |
Fibrohistiocytic | 14052 | 54.6 | 45.4 | 17.0 | 4.1 | 1.2 | 30.5 | 45.8 | 1.4 | 57.5 | 26.5 | 6.0 | 10.0 |
MPNST | 1969 | 53.7 | 46.3 | 18.2 | 13.6 | 3.1 | 27.6 | 31.5 | 6.0 | 46.4 | 23.4 | 12.0 | 18.2 |
Kaposi | 15226 | 94.8 | 5.2 | 10.7 | 2.9 | 1.4 | 5.9 | 31.8 | 47.2 | 0.0 | 0.0 | 0.0 | 100.0 |
Ewing family tumors | 356 | 53.1 | 46.9 | 10.1 | 13.2 | 8.4 | 39.3 | 25.3 | 3.7 | 30.3 | 27.5 | 30.3 | 11.8 |
Rhabdoid | 65 | 47.7 | 52.3 | 7.7 | 44.6 | 6.2 | 21.5 | 12.3 | 7.7 | 21.5 | 24.6 | 38.5 | 15.4 |
Liposarcomas | 7332 | 58.9 | 41.1 | 3.5 | 22.6 | 0.8 | 28.1 | 43.7 | 1.3 | 65.7 | 20.7 | 6.3 | 7.3 |
Leiomyosarcomas | 13023 | 35.2 | 64.8 | 4.1 | 60.9 | 1.5 | 17.1 | 13.4 | 3.0 | 50.1 | 19.3 | 20.2 | 10.5 |
Synovial | 1531 | 51.9 | 48.1 | 6.3 | 1.8 | 5.3 | 15.7 | 68.7 | 2.2 | 54.3 | 23.1 | 13.8 | 8.8 |
Blood vessel | 2685 | 45.6 | 54.4 | 24.6 | 14.2 | 7.3 | 31.8 | 15.5 | 6.6 | 38.8 | 24.6 | 20.2 | 16.5 |
Osseous\chondromatous | 654 | 59.9 | 40.1 | 8.0 | 0.3 | 0.9 | 36.2 | 52.3 | 2.3 | 47.1 | 32.7 | 12.7 | 7.5 |
ASPS | 117 | 46.2 | 53.8 | 1.7 | 10.3 | 2.6 | 18.8 | 63.2 | 3.4 | 32.5 | 9.4 | 46.2 | 12.0 |
Miscellaneous | 7901 | 49.2 | 50.8 | 9.3 | 25.0 | 7.6 | 26.8 | 24.2 | 7.2 | 34.8 | 21.0 | 24.6 | 19.5 |
Abbreviation: RMS: rhabdomyosarcomas; MPNST: malignant peripheral nerve sheath tumors; ASPS: alveolar soft parts sarcoma; Miscellaneous: Miscellaneous/unspecified soft tissue sarcomas including other fibromatous neoplasms. M: males; F: females; H&N: primary site of head and neck; Ab: primary site of intra-abdomen; Intra-T: primary site of intra-thorax; Trunk: primary site of trunk; Extre: primary site of extremities; L: localized; R: regional; D: distant; U: unstaged.